New Nordic biotech company

The Swiss biotech company Tillots Pharma opens a office in Stockholm, which will be run under private management.

By Sophia Carlsson

January 8, 2009 12:00 AM

Tillotts Pharma, a subsidary to the Swiss company Tillotts Pharma, starts under private management in Stockholm. The company is focused on gastroenterology and stand behind the drug Asacol, used against intestine inflammations. The drug’s turnover in the Nordic countries is almost SEK 170 million. The new Nordic Tillotts Pharma will continue to focus on Asacol.

{{ comments.count === 1 ? '1 comment' : comments.count > 1 ? '{0} comments'.replace('{0}', comments.count) : 'Write a comment' }}

By submitting the comment you accept the terms. See terms

Good comment behavior

Keep a good tone in your comments, avoid personal attacks and posts of marketing character. Apply only link on your comment if it is relevant to the debate.

Be aware that the debates are moderated by the portal's editorial team.

The comment has been created.

Your comment will not be visible until you activate it. In a few moments you will receive an email where you must click on a link to activate your comment.